Healthline
November 9, 2025
Share on PinterestA common drug used as an emergency contraceptive may also help lower breast cancer risk. Tom Werner/Getty Images Researchers say that a drug used […]
November 8, 2025
Share on PinterestA new study found that waist-to-height ratio was closely linked to heart disease risk than BMI or waist circumference. Ableimages/Getty Images A new study […]
November 6, 2025
Share on PinterestShort-term fasting is unlikely to have a significant impact on mental sharpness, according to new research. Johner Images/Getty Images Researchers report that intermittent fasting […]
November 5, 2025
Share on PinterestA new study raises concerns over long-term melatonin use and cardiovascular risks. Viktoriya Skorikova/Getty Images Researchers say people with insomnia who use melatonin supplements […]
Medscape
July 2, 2025
TOPLINE: Among Medicare beneficiaries with HIV, the proportion receiving at least one nonrecommended antiviral prescription decreased substantially from 5.1% in 2013 to 0.1% in 2021. METHODOLOGY: […]
July 2, 2025
TOPLINE: In a large cohort, long-acting lipoglycopeptides (laLGPs) demonstrated comparable effectiveness to standard-of-care antibiotics for step-down treatment of serious Gram-positive bacterial infections in both individuals who […]
July 2, 2025
TOPLINE: Kids and teens sleeping longer, even as little as an hour more, during the first week after a concussion were more likely to have worse […]
July 2, 2025
(Reuters) -Organon said on Wednesday it will the stop development of an experimental treatment it acquired through its purchase of Forendo Pharma, after the drug failed […]
FDA
December 18, 2025
FDA conducts inspections to evaluate compliance with risk evaluation and mitigation strategies (REMS) requirements to ensure the drug’s health benefits outweigh the risks for patients. Inspections […]
December 18, 2025
Docket Number: FDA-2023-D-5021 Issued by: Guidance Issuing Office Office of Inspections and Investigations Office of the Commissioner, Office of Clinical Policy and Programs Center for Biologics […]
December 18, 2025
For Immediate Release: August 25, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the […]
December 17, 2025
On December 17, 2025, the Food and Drug Administration (FDA) approved rucaparib (Rubraca, pharmaand GmbH) for adults with a deleterious BRCA mutation (BRCAm) (germline and/or somatic)-associated […]
